Abstract
Chronic respiratory illness is often difficult to manage and associate with challenges to overall health-specific quality of life issues. The mechanisms through which patients appraise health-related threats and manage coping resources to combat this threat are discussed. Early identification of psychosocial risk factors including depression and anxiety, as well as coping resources, may significantly influence the course of one’s disease and overall quality of life. Response to illness may be influenced by multiple factors and is highly variable from individual to individual. Premorbid psychological health is a predictor of the likely coping skills a patient has in place, as well as their emotional and cognitive abilities to manage the stressors of illness. However, individual experiences with disease, sensitivities to specific illness burden, limitations and threats to one’s resources and coping skills from the disease itself may take a heavy toll on the patient. The relationship between physical and mental health is in no way unidirectional. Though psychological hardiness may be protective against some diseases, it has been well established that mental illness is associated with higher risk for diseases such as cardiovascular illness, diabetes, and many cancers. In addition to premorbid risk factors that could challenge a patient’s response to illness, possible iatrogenic effects of treatment for respiratory illnesses in addition to the illness itself should be carefully tracked and managed during the course of treatment.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Doyle C, Dunt D, Ames D, Selvarajah S. Managing mood disorders in patients attending pulmonary rehabilitation clinics. Int J Chron Obstr Pulm Dis. 2013;8:15–20.
Goodwin RD, Scheckner B, Pena L, Feldman JM, Taha F, Lipsitz JD. A 10-year prospective study of respiratory disease and depression and anxiety in adulthood. Ann Allergy Asthma Immunol. 2014;113:565–70.
Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Mental Health Findings. NSDUH Series H-47, HHS Publication No. (SMA) 13-4805. 2013. Rockville, MD, Substance Abuse and Mental Health Services Administration.
Chang CK, Hayes RD, Broadbent M, et al. All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study. BMC Psychiatry. 2010;10:77.
Miller C, Bauer MS. Excess mortality in bipolar disorders. Curr Psychiatry Rep. 2014;16:499.
Schoepf D, Heun R. Bipolar disorder and comorbidity: increased prevalence and increased relevance of comorbidity for hospital-based mortality during a 12.5-year observation period in general hospital admissions. J Affect Disord. 2014;169:170–8.
Hasler G, Gergen PJ, Kleinbaum DG, et al. Asthma and panic in young adults: a 20-year prospective community study. Am J Respir Crit Care Med. 2005;171:1224–30.
Lichtman JH, Froelicher ES, Blumenthal JA, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129:1350–69.
Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013;144:766–77.
Burg MA, Adorno G, Lopez ED, et al. Current unmet needs of cancer survivors: analysis of open-ended responses to the American Cancer Society Study of Cancer Survivors II. Cancer. 2015;121:623–30.
Abrams TE, Vaughan-Sarrazin M, Van der Weg MW. Acute exacerbations of chronic obstructive pulmonary disease and the effect of existing psychiatric comorbidity on subsequent mortality. Psychosomatics. 2011;52:441–9.
Willgoss TG, Yohannes AM. Anxiety disorders in patients with COPD: a systematic review. Respir Care. 2013;58:858–66.
Giltay EJ, Nissinen A, Giampaoli S, Zitman FG, Kromhout D. Low respiratory function increases the risk of depressive symptoms in later life in men. Psychosom Med. 2010;72:53–60.
Hanania NA, Mullerova H, Locantore NW, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011;183:604–11.
Kumar GK. Hypoxia. 3. Hypoxia and neurotransmitter synthesis. Am J Physiol Cell Physiol. 2011;300:C743–51.
van Dijk EJ, Vermeer SE, de Groot JC, et al. Arterial oxygen saturation, COPD, and cerebral small vessel disease. J Neurol Neurosurg Psychiatry. 2004;75:733–6.
El-Ad B, Lavie P. Effect of sleep apnea on cognition and mood. Int Rev Psychiatry. 2005;17:277–82.
Forlenza MJ, Miller GE. Increased serum levels of 8-hydroxy-2’-deoxyguanosine in clinical depression. Psychosom Med. 2006;68:1–7.
Kirkham PA, Barnes PJ. Oxidative stress in COPD. Chest. 2013;144:266–73.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this chapter
Cite this chapter
Rose, M., Sharafkhaneh, A. (2017). Overview of Psychological Considerations in the Management of Patients with Chronic Respiratory Conditions. In: Sharafkhaneh, A., Yohannes, A., Hanania, N., Kunik, M. (eds) Depression and Anxiety in Patients with Chronic Respiratory Diseases. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7009-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7009-4_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-7007-0
Online ISBN: 978-1-4939-7009-4
eBook Packages: MedicineMedicine (R0)